21 May 2013
Keywords: novartis, diovan, boosts, artery, elasticity, study, published
Article | 16 June 2008
A study published in the June issue of Hypertension demonstrates that the leading angiotensin receptor blocker Novartis Diovan (valsartan) in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 June 2008
20 May 2013
© 2013 thepharmaletter.com